Catalpol Protects Against Pulmonary Fibrosis Through Inhibiting TGF-β1/Smad3 and Wnt/β-Catenin Signaling Pathways

Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease characterized by fibroblast proliferation and extracellular matrix remodeling; however, the molecular mechanisms underlying its occurrence and development are not yet fully understood. Despite it having a variety of beneficial pharmacologic...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Pharmacol
Autors principals: Yang, Fan, Hou, Zhen-feng, Zhu, Hao-yue, Chen, Xiao-xuan, Li, Wan-yang, Cao, Ren-shuang, Li, Yu-xuan, Chen, Ru, Zhang, Wei
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2021
Matèries:
Pharmacology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7878558/
https://ncbi.nlm.nih.gov/pubmed/33584272
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.594139
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars